Erasmus MC, Department of Surgery, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Molecular Biology, Radboud University, Nijmegen, The Netherlands.
Clin Transl Med. 2021 Dec;11(12):e566. doi: 10.1002/ctm2.566.
The well-established 3D organoid culture method enabled efficient expansion of cholangiocyte-like cells from intrahepatic (IHBD) and extrahepatic bile duct (EHBD) tissue biopsies. The extensive expansion capacity of these organoids enables various applications, from cholangiocyte disease modelling to bile duct tissue engineering. Recent research demonstrated the feasibility of culturing cholangiocyte organoids from bile, which was minimal-invasive collected via endoscopic retrograde pancreaticography (ERCP). However, a detailed analysis of these bile cholangiocyte organoids (BCOs) and the cellular region of origin was not yet demonstrated. In this study, we characterize BCOs and mirror them to the already established organoids initiated from IHBD- and EHBD-tissue. We demonstrate successful organoid-initiation from extrahepatic bile collected from gallbladder after resection and by ERCP or percutaneous transhepatic cholangiopathy from a variety of patients. BCOs initiated from these three sources of bile all show features similar to in vivo cholangiocytes. The regional-specific characteristics of the BCOs are reflected by the exclusive expression of regional common bile duct genes (HOXB2 and HOXB3) by ERCP-derived BCOs and gallbladder-derived BCOs expressing gallbladder-specific genes. Moreover, BCOs have limited hepatocyte-fate differentiation potential compared to intrahepatic cholangiocyte organoids. These results indicate that organoid-initiating cells in bile are likely of local (extrahepatic) origin and are not of intrahepatic origin. Regarding the functionality of organoid initiating cells in bile, we demonstrate that BCOs efficiently repopulate decellularized EHBD scaffolds and restore the monolayer of cholangiocyte-like cells in vitro. Bile samples obtained through minimally invasive procedures provide a safe and effective alternative source of cholangiocyte organoids. The shedding of (organoid-initiating) cholangiocytes in bile provides a convenient source of organoids for regenerative medicine.
已建立的 3D 类器官培养方法可从肝内 (IHBD) 和肝外胆管 (EHBD) 组织活检中高效扩增胆管细胞样细胞。这些类器官的广泛扩增能力使其能够应用于各种领域,从胆管细胞疾病建模到胆管组织工程。最近的研究表明,通过内镜逆行胰胆管造影术 (ERCP) 微创收集胆汁,培养胆管细胞类器官是可行的。然而,尚未对这些胆汁胆管细胞类器官 (BCO) 和细胞起源区域进行详细分析。在这项研究中,我们对 BCO 进行了特征描述,并将其与已建立的从 IHBD 和 EHBD 组织起始的类器官进行了比较。我们证明了从切除后的胆囊、ERCP 或经皮经肝胆管造影术收集的肝外胆汁以及来自各种患者的经皮经肝胆管造影术成功起始类器官。这三种来源的胆汁起始的 BCO 均显示出与体内胆管细胞相似的特征。BCO 的区域特异性特征通过 ERCP 衍生的 BCO 和胆囊衍生的 BCO 中区域共同胆管基因 (HOXB2 和 HOXB3) 的特异性表达反映出来,而胆囊衍生的 BCO 表达胆囊特异性基因。此外,BCO 具有有限的肝源性分化潜能,与肝内胆管细胞类器官相比。这些结果表明,胆汁中的类器官起始细胞可能来自局部 (肝外) 起源,而不是肝内起源。关于胆汁中类器官起始细胞的功能,我们证明 BCO 能够有效地重新填充脱细胞的 EHBD 支架,并在体外恢复胆管细胞样细胞的单层。通过微创程序获得的胆汁样本为胆管细胞类器官提供了一种安全有效的替代来源。胆管细胞 (类器官起始) 在胆汁中的脱落为再生医学提供了方便的类器官来源。